News

NEWS CENTER
Your present position:
Home >
News
  • 07/31
    2020
    Documents, samples, reference standards and special laboratory material requirement for Registration

    Documents, samples, reference standards and special laboratory material requirement for Registration

  • 07/31
    2020
    Procedures & Technical Requirements for Drug Registration Inspection  (Version 2020)

    Procedures & Technical Requirements for Drug Registration Inspection (Version 2020)

  • 07/01
    2020
    Charging Rates for Drug Registration

    Charging Rates for Drug Registration

    Charging Rates for Drug Registration
  • 04/08
    2020
    Baidu promotion materials

    Baidu promotion materials

    Baidu promotion materials
  • 03/30
    2020
    Exhibiting in the coming API China

    Exhibiting in the coming API China

    Exhibiting in the coming 84th API & Interprex China (May 13 - May 15)
  • 03/30
    2020
    Successful renewal of GSP Certificate of Leawell

    Successful renewal of GSP Certificate of Leawell

    Successful renewal of GSP Certificate of Leawell
  • 03/23
    2020
    Policy updates (as at 16th July 2019) (56th Announcement in 2019)

    Policy updates (as at 16th July 2019) (56th Announcement in 2019)

    Policy updates (as at 16th July 2019) (56th Announcement in 2019)
  • 03/23
    2020
    Ports that are approved by the State Council of China for importing pharmaceutical materials

    Ports that are approved by the State Council of China for importing pharmaceutical materials

    The 22 ports that are approved by the state council of China to import pharmaceutical materials into China (as at July 2019)
  • 03/18
    2020
    VAT Discounts for the First Batch of Orphan Drugs Officially Landed

    VAT Discounts for the First Batch of Orphan Drugs Officially Landed

    VAT Discounts for the First Batch of Orphan Drugs Officially Landed
  • 03/18
    2020
    NMPA Issued the Announcement on the Cessation of Production, Sale and Use of Furazolidone-Containing

    NMPA Issued the Announcement on the Cessation of Production, Sale and Use of Furazolidone-Containing

    NMPA Issued the Announcement on the Cessation of Production, Sale and Use of Furazolidone-Containing Compound Preparations
  • Jump to the first page